Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 9,434 | 18,437 | 32,166 |
| Gross Profit | N/A | N/A | 9,434 | 18,437 | 32,166 |
| Operating Expenses | 279,298 | 214,054 | 138,577 | 97,430 | 63,467 |
| Operating Income | -279,298 | -214,054 | -129,143 | -78,993 | -31,301 |
| Interest Expense | 0 | 0 | 0 | 0 | 484 |
| Other Income | 40,879 | 31,369 | 3,888 | 105 | 2,691 |
| Pre-tax Income | -238,419 | -182,685 | -125,255 | -78,888 | -29,094 |
| Income Tax | -4,089 | -292 | 118 | -6 | -257 |
| Net Income Continuous | -234,330 | -182,393 | -125,373 | -78,882 | -28,837 |
| Net Income | $-234,330 | $-182,393 | $-125,373 | $-78,882 | $-28,837 |
| EPS Basic Total Ops | -3.01 | -2.73 | -2.06 | -1.77 | -0.81 |
| EPS Basic Continuous Ops | -3.01 | -2.73 | -2.07 | -1.81 | -0.83 |
| EPS Diluted Total Ops | -3.01 | -2.73 | -2.06 | -1.77 | -0.81 |
| EPS Diluted Continuous Ops | -3.01 | -2.73 | -2.07 | -1.81 | -0.83 |
| EPS Diluted Before Non-Recurring Items | -3.01 | -2.73 | -2.06 | -1.77 | -0.81 |
| EBITDA(a) | $-276,738 | $-211,993 | $-127,519 | $-78,087 | $-30,441 |